Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma

Analytical Biochemistry

Volumn 322, Issue 2, 2003, Pages 283-286

  Makowski, Gregory S ^a   Ramsby, Melinda L ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Farmington Valley Arthr/R LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

HUMAN PLASMAS; MATRIX METALLOPROTEINASE-9;

CHEMISTRY;

CITRATE SODIUM; CITRIC ACID; EDETIC ACID; FIBRILLAR COLLAGEN; GELATINASE A; GELATINASE B; HEPARIN; LITHIUM; POLYACRYLAMIDE GEL; PROTEINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME RELEASE; ENZYME STABILITY; GEL ELECTROPHORESIS; HUMAN; MOLECULAR WEIGHT; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; ZYMOGRAPHY;

EID: 0142226896     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.07.030     Document Type: Article

References (20)

1. Woessner J.F. Jr. The family of matrix metalloproteinases. Ann. N Y Acad. Sci. 731:1994;11-21.
2. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378:1997;151-160.
3. Cockett M.I., Murphy G., Birch M.L., O'Connell J.P., Crabbe T., Millican A.T., Hart I.R., Docherty A.J. Matrix metalloproteinases and metastatic cancer. Biochem. Soc. Symp. 63:1998;295-313.
4. Zeng Z.S., Cohen A.M., Guillem J.G. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis. 20:1999;749-755.
5. Dumas V., Kanitakis J., Charvat S., Eurard S., Faure M., Claudy A. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res. 19:1999;2929-2938.
6. Kerkela E., Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp. Dermatol. 12:2003;109-125.
7. Vartio T., Baumann M. Human gelatinase/type IV procollagenase is a regular plasma component. FEBS Lett. 255:1989;285-289.
8. Hibbs M.S., Hasty K.A., Seyer J.M., Kang A.H., Mainardi C.L. Biochemical and immunological characterization of the secreted forms of neutrophil gelatinase. J. Biol. Chem. 260:1985;2493-2500.
9. Jung K., Nowak L., Lein M., Henke W., Schnorr D., Loening S.A. Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors in blood. Clin. Chem. 42:1996;2043-2045.
10. Jung K., Laube C., Lein M., Lichtinghagen R., Tschesche H., Schnorr D., Loening S.A. Kind of sample as a preanalytical determinant of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clin. Chem. 44:1998;1060-1062.
11. Jung K., Lein M., Laube C., Lichtinghagen R. Blood specimen collection methods influence the concentration and diagnostic validity of matrix metalloproteinase 9 in blood. Clin. Chim. Acta. 314:2001;241-244.
12. Mannello F. Effects of blood collection methods on gelatin zymography of matrix metalloproteinases. Clin. Chem. 49:2003;339-340.
13. Makowski G.S., Ramsby M.L. Binding of latent matrix metalloproteinase-9 to fibrin: activation via a plasmin dependent pathway. Inflammation. 22:1998;287-305.
14. Makowski G.S., Ramsby M.L. Binding of latent matrix metalloproteinase-9 to fibrin is mediated by amorphous calcium-phosphate. Inflammation. 22:1998;599-617.
15. Heussen C., Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102:1980;196-202.
16. Makowski G.S., Ramsby M.L. Calibrating gelatin zymograms with human gelatinase standards. Anal. Biochem. 236:1996;353-356.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Murphy G., Crabbe T. Gelatinase A and B. Methods Enzymol. 248:1995;470-488.
19. Makowski G.S., Ramsby M.L. Identification and partial characterization of three calcium- and zinc-independent gelatinases constitutively present in human circulation. Biochem. Mol. Biol. Int. 46:1998;1043-1053.
20. Pucci-Minafra I., Minafra S., La Rocca G., Barancea M., Fontana S., Alaimo G., Okada Y. Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis. Matrix Biol. 20:2001;419-427.